Vol. 10: Vol. 10 No. 1 (2023): January-December 2023

Published: 2023-01-16

Original research article

Cost per responder for vedolizumab and ustekinumab in Crohn’s disease patients after failure of TNF-α inhibitors in Italy

Roberto Ravasio, Raffaella Viti, Antonio Saverio Roscini

13-21
Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy

Francesca Fiorentino, Beatrice Canali, Paolo Morelli, Federica Demma

6-12

Point of view

Manuscript formatting, delayed peer-reviews, and overemphasizing the impact factor: can something be done?

Vijay Kothari

4-5
- PDF (English)
- ePub
- html
Clinical trial units and clinical research coordinators: a system facing crisis?

Stefano Stabile, Rosita Cenna, Valentina Sinna, Franchina Veronica, Francesca Mannozzi, Irene Federici, Sara Testoni, Celeste Cagnazzo

1-3
- PDF
- ePub
- html